小智港股覆盤 | 10月24日
今日,港股三大指數集體下跌。截止收盤,恆生指數大跌6.36%,報15180點。國企指數大跌7.3%,報5114點。恆生科技指數大跌9.65%,報2801點。市場約200只個股上漲,1657只個股下跌。成交額突破1617.53億港幣,和昨天同期相比增長72.13%。南下資金淨流入66.91億港幣。

盤面上,航天國防板塊集體拉昇。中航科工漲超5%。中航科工再漲超7%,軍工企業三季度業績亮眼,公司連續增持中航電子A股股份。

電力板塊活躍。長江基建集團漲超4%;中電控股漲超1%。

能源設備板塊活躍。惠生工程漲超5%;中海油田服務漲超4%。中海油田服務漲超4%,與中東地區一流國際石油公司簽署總價約140億元鑽井平臺服務合同。

電商板塊全線走低。京東健康、美團-W等多股跌超14%;中國儒意、京東集團-SW等多股跌超13%;寶尊電商-SW跌超11%。國家藥監局副局長調研叮噹快藥、美團、阿裏健康等平臺;國海證券:維持京東集團-SW“買入”評級,目標價291港元。

菸草板塊暴跌。思摩爾國際跌超12%。大和降思摩爾國際評級至「持有」,目標價削至9元。

互聯網醫療板塊全線走低。阿裏健康跌超14%;醫脈通跌超13%;醫渡科技跌超12%;平安好醫生跌超7%。國家藥監局副局長調研叮噹快藥、美團、阿裏健康等平臺;醫脈通因購股權獲行使發行30萬股。

uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.